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GSH compartmentationApoptosis is a highly organized form of cell death that is important for tissue homeostasis, organ develop-
ment and senescence. To date, the extrinsic (death receptor mediated) and intrinsic (mitochondria derived)
apoptotic pathways have been characterized in mammalian cells. Reduced glutathione, is the most prevalent
cellular thiol that plays an essential role in preserving a reduced intracellular environment. glutathione pro-
tection of cellular macromolecules like deoxyribose nucleic acid proteins and lipids against oxidizing, envi-
ronmental and cytotoxic agents, underscores its central anti-apoptotic function. Reactive oxygen and
nitrogen species can oxidize cellular glutathione or induce its extracellular export leading to the loss of intra-
cellular redox homeostasis and activation of the apoptotic signaling cascade. Recent evidence uncovered a
novel role for glutathione involvement in apoptotic signaling pathways wherein post-translational
S-glutathiolation of protein redox active cysteines is implicated in the potentiation of apoptosis. In
the present review we focus on the key aspects of glutathione redox mechanisms associated with ap-
optotic signaling that includes: (a) changes in cellular glutathione redox homeostasis through
glutathione oxidation or GSH transport in relation to the initiation or propagation of the apoptotic
cascade, and (b) evidence for S-glutathiolation in protein modulation and apoptotic initiation.
© 2012 Elsevier B.V. All rights reserved.1. Introduction: Overview of apoptotic signaling pathways
Apoptosis or programmed cell death is a physiologically conserved
mechanism that plays an important role in embryonic development
and tissue homeostasis in all organisms [1]. The term “apoptosis” was
ﬁrst introduced by Kerr et al. to describe an active and highly organized
form of cell death characterized by biochemical events that result in
speciﬁc morphological changes including cell shrinkage, chromatin
condensation, nuclear fragmentation, and membrane blebbing [2]. The
resultant apoptotic bodies enclosing cellular debris are engulfed by
macrophages, a process that prevents an inﬂammatory response and
damage to neighboring cells. Apoptosis can be triggered by engagement
of a death receptor at the plasmamembrane (the extrinsic pathway) orial; ANT, adenine nucleotide translo
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rights reserved.by mitochondria-derived signals (the intrinsic pathway) (Fig. 1). Both
pathways concur in the activation of caspases, a family of cysteine pro-
teases that cleave speciﬁc target proteins leading to the morphological
features characteristic of apoptotic death.
The death receptor pathway is triggered by external stimuli such
as the tumor necrosis factor (TNF) family of proteins including
TNFα, Fas/CD95 ligand, TRAIL or TWEAK (TNF-like weak inducer of
apoptosis). Binding of the pro-apoptotic ligand to the death receptor
(DR), namely TNFR1, Fas, Trail R1/Trail R2 and DR4, respectively, on
the plasma membrane causes downstream signaling that culminates
in activation of the executioner caspases, caspase-3 and caspase-7.
Initial stages of this process involve receptor oligomerization and re-
lease of control proteins, such as FLICE (caspase-8)-inhibitorycase; Apaf-1, apoptotic protease-activating factor-1; ASK-1, apoptosis signal-regulating
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Fig. 1. Extrinsic and intrinsic apoptosis. The extrinsic or death receptor-mediated pathway is
mediated by sequential engagement of speciﬁc ligands such as FasL, TNF-α, TRAIL, and
TWEAK with cognate receptors, formation of the death-inducing signaling complex, and ac-
tivation of initiator caspases 8 and/or 10. In type I cells, caspase 8 activates effector caspases 3,
6 or 7, while in type II cells, caspase 8 truncates pro-apoptotic Bid and engages themitochon-
dria. The intrinsic or mitochondrial pathway is initiated by Bax/Bak-induced mitochondrial
membrane permeabilization and mitochondria-to-cytosol release of apoptogenic factors in
response to apoptotic stimuli such as xenobiotics, reactive oxygen/nitrogen species, or UV ra-
diation. The apoptogenic factorsmediate caspase-dependent and independent apoptotic sig-
naling within the cytosol. Cytochrome c-Apaf-1 apoptosome complex activates pro-caspase
9, the initiator caspase for downstream activation of caspases 3, 6, or 7 that execute the
ﬁnal steps of apoptosis. The apoptotic signal is further enhanced by apoptogenic Smac/Diablo
and Omi/HtrA2 that neutralize caspase inhibitors. In caspase-independent signaling,
pro-apoptotic AIF and endonuclease G are translocated to the nucleus and induce DNA frag-
mentation. AIF: apoptosis inducing factor; Apaf-1: apoptotic protease-activating factor-1;
Bax/Bak, pro-apoptotic proteins; Bid, BH3-only pro-apoptotic protein; cyt c: cytochrome c;
DISC: death-inducing signaling complex; endoG, endonuclease G; FADD: Fas-associated
death domain; FasL: Fas ligand; IAPs: inhibitors of apoptosis proteins; Omi/HtrA2: high tem-
perature requirement A2 serine protease; Smac, second mitochondria-derived activator of
caspases; tBid, truncated form of Bid; TNF-α: tumor necrosis factor-α; TRAIL: TNF-related
apoptosis-inducing ligand; TRADD: TNF receptor-associated death domain; TRAF-2: TNF
receptor-associated factor-2.
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receptor-interacting protein 1 (RIP1) from the receptor. Subsequent
recruitment of adaptor proteins containing death domains or death
effector domains (Fas-associated death domain (FADD) or TNF re-
ceptor type 1-associated death domain (TRADD)) results in the for-
mation of DISC (death-inducing signaling complex) where initiator
caspases, such as caspase-8 or caspase-10 are recruited and activat-
ed. Downstream signaling and apoptotic outcome are cell type spe-
ciﬁc. In type I cells, initiator caspases directly cleave and activate
executioner caspases that leads to cellular apoptosis [3]. In type II
cells, apoptosis occurs through engagement of mitochondrial apo-
ptotic signaling via activation of pro-apoptotic Bid protein by acti-
vated caspase-8 [4].
The central mediator of the intrinsic apoptotic pathway is the
mitochondria. A variety of apoptotic stimuli like ROS, RNS and
mitochondrial DNA damage can induce permeabilization of the mito-
chondrial outermembrane and release ofmitochondrial apoptogenic fac-
tors into the cytosol (Fig. 1) [5]. Once in the cytosol, apoptotic proteins
such as cytochrome c (cyt c), apoptosis inducing factor (AIF), second
mitochondria-derived activator of caspases (Smac)/direct inhibitor of ap-
optosis binding protein with low pI (Diablo), and endonuclease G
(endoG), initiate caspase-dependent and caspase-independent mecha-
nisms that promote apoptosis. In caspase-dependent signaling, cyt c
binds to the adaptor protein apoptotic protease-activating factor-1
(Apaf-1), resulting in apoptosome assembly. The dimerization and activa-
tion of pro-caspase-9 at this cytosolic complex is associated with down-
stream activation of the effector caspases-3 and -7. The function of the
active caspases is blocked by the binding of inhibitors of apoptotic pro-
teins (IAP). Smac/Diablo released from the mitochondria binds to and in-
hibits the effects of IAPs, thereby indirectly enhancing the activation of
caspases. In addition, AIF and endoG translocate to the nucleus and induce
nuclear chromatin condensation and large-scale DNA fragmentation in a
caspase-independent manner [6]. Whether the quantitative contribution
of caspase-dependent or -independent mechanisms to cell apoptosis is
cell type or stimuli speciﬁc remains unclear and warrants further
investigation.
Despite much research, the mechanisms by which mitochondrial
apoptogenic factors are released into the cytosol are unresolved. Per-
meabilization of the outer mitochondrial membrane (OMM) through
opening of the mitochondrial permeability transition pore (PTP), or
through pore formation within OMM by pro-apoptotic Bax or Bak
[7,8] has been implicated in this process. PTP, comprising of
voltage-dependent anion channel (VDAC), adenine nucleotide
translocase (ANT), and cyclophilin D, is located at contact sites be-
tween the inner and OMM [7], and PTP opening can be modulated
by mitochondrial membrane potential (ΔΨ), elevated Ca2+, oxida-
tive stress, thiol oxidation, or altered pyridine nucleotide status [9].
Since different apoptotic stimuli mediate VDAC oligomerization
and channel formation, it is conceivable that a sufﬁciently large
channel could allow mitochondria-to-cytosol translocation of
apoptogenic factors [10,11]. Moreover, OMM permeabilization
and factor release could result from channel formation through
Bax, Bak, and Bid conformational changes and homo- or
hetero-oligomerization within the OMM [12]. This notwithstand-
ing, the notion that mitochondrial release of apoptogenic factors
occurs through PTP or Bax mediated OMM permeabilization re-
mains an open question.
The unfolding protein response (UPR) results from the accumulation
of misfolded protein in the endoplasmic reticulum (ER) [13] wherein
sustained UPR culminates in cell apoptosis. Key among the mechanisms
suggested in apoptosis initiation is the release of ERCa2+ stores. Excessive
Ca2+ accumulation within mitochondria leads to mitochondrial dysfunc-
tion,ΔΨ collapse and release ofmitochondrial apoptogenic factors. An in-
crease in ROS production consequent to oxidative protein misfolding
and mitochondrial dysfunction was also linked to UPR-dependent
apoptosis.2. Control of intracellular glutathione (GSH) redox balance
2.1. GSH synthesis and homeostasis
The tripeptide glutathione, GSH, L-γ-glutamyl-L-cysteinyl glycine,
is a ubiquitous low-molecular-weight thiol with concentrations
reaching millimolar levels (1–10mM) within cells and micromolar
levels (10–30μM) in plasma [14,15]. The biologically active form, re-
duced GSH, is a key contributor to the cellular antioxidant defense
system and to the maintenance of the intracellular redox milieu for
the preservation of thiol–disulﬁde redox states of proteins. GSH is
also involved in cellular signaling, regulation and redox activation of
transcription factors, and thiol–disulﬁde exchange reactions. GSH ox-
idation to glutathione disulﬁde, GSSG, results in intracellular redox
imbalance as reﬂected in a decreased GSH-to-GSSG ratio, a condition
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creasing evidence supports the interaction of GSSG with reactive
cysteines of proteins to form mixed disulﬁdes, a process termed
S-glutathiolation (also called S-glutathionylation) [16]. Indeed,
GSH-dependent post-translational modiﬁcation of protein cysteines
is emerging to be a major biological mechanism in the redox regula-
tion of metabolic pathways, including cell fate (see Sections 3–5).
The biological control of intracellular GSH homeostasis through
consumption and supply is an intricately balanced process that averts
oxidative stress and apoptosis. Cellular GSH availability is maintained
by de novo synthesis from precursor amino acids, (glutamate, cyste-
ine, and glycine), reduction of GSSG by glutathione reductase (GR),
and uptake from exogenous GSH sources across plasma membranes
(Fig. 2). GSH synthesis takes place only in the cytosolic compartment
in two consecutive ATP-dependent reactions catalyzed by glutamate
cysteine ligase (GCL) and GSH synthase (GS) [17], the former being
a rate-limiting step in the biosynthetic pathway. The control of GCL
function, through transcriptional regulation of GCL catalytic (GCLc)
or modulatory (GCLm) subunits [18], or through product (GSH) feed-
back, is central to cellular GSH homeostasis. Intracellular GSH redox
state is also maintained by GR-catalyzed GSSG reduction, an efﬁcient
process that depends on the supply of the reductant, NADPH, provid-
ed mainly by the pentose phosphate shunt [17]. An important mech-
anism for GSH homeostasis characteristic of epithelial cells such as
enterocytes [19] and proximal tubular cells [20] is the uptake of intact
GSH via plasma membrane speciﬁc carriers. Additionally, in the
lumen of these transport epithelia (kidney, small intestine, pancreas,
bile duct) GSH hydrolysis provides precursor amino acids that are
recycled for intracellular GSH synthesis (Fig. 2). Extracellular GSH,
which is not susceptible to cleavage by conventional proteolytic en-
zymes, can undergo hydrolysis, catalyzed by the consecutive actions
of γ-glutamyl transpeptidase (GGT) and dipeptidase. GGT is an ecto-
enzyme located at the apical plasma membrane and is the only
known enzyme that cleaves GSH to glutamate and cysteinyl-glycine
[21]; subsequent cysteinyl-glycine hydrolysis by dipeptidase yields
the constituent amino acids. Thus, the so called γ-glutamyl cycle,
comprising the enzymatic reactions in intracellular GSH synthesisFig. 2. Cellular GSH homeostasis in mammalian cells. Major pathways for maintaining intracellu
uptake.GSH synthesis takesplace only in the cytosolic compartments in twoATP-dependent reactio
cells can import intact GSH from the extracellular space via speciﬁc plasmamembrane transporters
endoplasmic reticulum, creating distinct and independently regulated subcellular redox pools. As
reactions with electrophiles, (b) glutathione peroxidase-catalyzed reduction of hydroperoxides, a
Glutathione reductase-catalyzed regeneration of GSH from GSSG occurs at the expense of NADPH,
lium, extracellular GSH is sequentially hydrolyzed by γ-glutamyl transferase and dipeptidase to yie
the γ-glutamyl cycle, this GSH hydrolysis–resynthesis cycle reportedly constitutes a major system
constituent amino acids, glutamate, cysteine and glycine occurs only extracellularly in two sequen
ferase; DP, dipeptidase; GCL, glutamate-cysteine ligase; Grx, glutaredoxin; GSH, glutathione; GSSG,
reductase; GST, glutathione-S-transferase; H2O2, hydrogen peroxide; LOOH, lipid hydroperoxidesand extracellular GSH degradation (Fig. 2), could be a main mecha-
nism for preserving cellular GSH homeostasis in transport epithelial
cells.
The extent of the signiﬁcant role that GGT and the γ-glutamyl cycle
play in GSH synthesis in other cell types has not been addressed. Interest-
ingly, in themammalian brain, GGT activity appears to be associatedwith
blood–brain barrier function. In particular, the endothelium of capillaries
exhibited higher GGT activity than those of larger vessels [22]. What this
means is that the endothelial monolayer in cerebral small vessels will
likely be highly sensitive to the ﬂuctuation in plasma GSH levels and
thereby be susceptible to oxidative injury. Additionally, GGT-catalyzed
metabolismof S-nitrosoglutathione (GSNO) couldmediate the bioactivity
of GSNO and/or nitric oxide in the cerebral microvasculature [22].
2.2. GSH distribution in subcellular compartments
Cellular GSH is compartmentalized into distinct pools within the cy-
tosol, mitochondria, ER, and nucleus. Cytosolic GSH is also exported into
the extracellular space such as plasma or bile [23] and constitutes a
unique extracellular GSH reserve pool available to different tissues.
Within each subcellular compartments, GSH exhibits speciﬁc turnover
rate, GSH and GSSG distribution, redox potential and control of cellular
activities [24]. Early studies indicate that the cytosolic GSH pool, typical-
ly atmillimolar levels inmost cell types (1–10mM) accounts for ~85% of
the total cellular GSH [14]. Cytosolic GSH is predominantly in the re-
duced state, and a highly reduced GSH-to-GSSG ratio (in excess of
100-to-1 in liver cells) is normally maintained [14].
Mitochondrial GSH (mtGSH) is an independently controlled redox
pool with a matrix GSH turnover rate of 30h, that is >10-fold slower
than that in the cytosol [25,26]. Nevertheless, mtGSH concentration is
high, between 5 and 10mM; levels that comprise ~10–15% of the cellu-
lar GSH in the liver [25] and ~30% in the kidney [27]. Matrix GSH is
maintained by cytosol-to-mitochondria GSH translocation which oc-
curs via mitochondrial carriers located in the inner membrane [28].
The dicarboxylate (DIC) and 2-oxoglutarate (OGC) carriers are the
major mtGSH transporters in kidney and liver [29,30]; an additional
tricarboxylate carrier is implicated in brain mtGSH transport [31]. Inlar GSH balance include de novo synthesis, regeneration from GSSG, and extracellular GSH
ns catalyzedbyγ-glutamate-cysteine ligase andglutathione synthase. Additionally, epithelial
, such asMRP. Post synthesis, cytosolicGSH is distributedwithin themitochondria, nucleus, or
an antioxidant, intracellular GSH participates in: (a) glutathione-S-transferase-conjugation
nd (c) glutaredoxins and glutathione-S-transferase catalyzed reduction of protein-disulﬁdes.
generated from glucosemetabolism in the pentose phosphate pathway. In transport epithe-
ld glutamate, cysteine and glycine that are recycled for intracellular GSH synthesis. Known as
for intracellular GSH homeostasis in transport epithelial cells. The degradation of GSH to its
tial steps catalyzed by γ-glutamyl transferase and dipeptidase (DP). γ-GT, γ-glutamyl trans-
glutathione disulﬁde; GS, glutathione synthase; Gpx, glutathione peroxidase; GR, glutathione
; PPP, pentose phosphate pathway; Pr-SSG, S-glutathiolated protein.
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protein at the mitochondria membrane reportedly binds GSH via the
BH3 groove, resulting in local GSH accumulation and increased in
mtGSH transport [32]. Moreover, Bcl-2-OGC transporter association
and facilitated mtGSH uptake afforded protection of these neurons
against oxidative stress-induced apoptosis [33]. Interestingly, the mito-
chondrial intermembranal space exhibits a more oxidized milieu than
that of the matrix, and is believed to favor disulﬁde bond formation in
small and soluble proteins, a process that involves sulfhydryl oxidase,
Erv1, and the receptor Mia40/Tim40 [34]. The distinct difference in
GSH redox potential of the mitochondrial matrix and intermembranal
space illustrates the complexity of redox regulation in the mitochon-
dria, and underscores the importance of the organelle in redox signaling
and control of cellular function.
The nucleus similarly exhibits a distinct and independently con-
trolled GSH pool that is important in maintaining the redox status of nu-
clear proteins and the integrity of nuclear DNA against oxidant-induced
damage [35,36]. Precisely how cytosol-to-nuclear GSH transport is
achieved is unclear; a currentmechanism of passive diffusion via nuclear
pores has been suggested. Early studies in HeLa cells also implicated a
role for Bcl-2 in controlling nuclear GSH levels as evidenced by the corre-
spondence of signiﬁcant accumulation of Bcl-2 protein in the nuclear
membrane with increased accumulation of nuclear GSH accumulation
[37]. Regardless of import mechanism, the nuclear GSH pool is dynamic,
that is, responsive to cellular activities, notably during cell cycle progres-
sion. Speciﬁcally, while equal GSH distribution between nucleus and cy-
tosol characterizes cells at conﬂuency, higher nuclear-to-cytosol GSH
ratios favor cell proliferation [38]. Such nuclear accumulation of GSH
is expected to optimize redox signaling events during the various
stages of the cell cycle, including DNA synthesis, replication and
chromatin reorganization [22]. Signiﬁcantly, our recent studies
showed that inhibition of endothelial GSH synthesis and GSH de-
pletion elicited a lengthening of the cell cycle S-phase resident
time (Busu and Aw, unpublished). This suggests that a disrupted
cellular GSH as occurs during oxidative stress, alongside a delayed
S-to-G2 transition could severely compromise tissue growth, repair
or regeneration, and potentially promote cell apoptosis, a deleteri-
ous scenario for organ function.
Unlike the other subcellular organelles, the GSH redox pool within
the ER is highly oxidized, but an increased GSSG-to-GSH ratio is not
maintained through GSSG transport across ER membrane [39]. Recent
evidence indicates that only GSH enters ER from the cytosol that re-
sults in GSH concentrations that are similar to those in the cytosol, be-
tween 2 and 10mM [23]. However, a signiﬁcant proportion of GSH is
present as mixed protein disulﬁdes, a modiﬁcation that is believed to
protect proteins against a highly oxidized environment within the ER;
GSH-to-GSSG ratios between 3-to-1 and 1-to-1 were reported [39],
which favor the formation of disulﬁde bonds in nascent proteins.
The protein disulﬁde isomerase (PDI) and ER-resident endoplasmic
oxidoreductin 1 (Ero1) are major players in oxidative protein folding.
It is the PDI/Ero1-dependent formation of disulﬁde bonds and GSH
oxidation to GSSG that maintains the highly oxidized GSH-to-GSSG
ratio. This process of GSH oxidation is tightly regulated; either an ex-
cessively reduced milieu or accumulated GSSG in the ER lumen can
trigger the UPR and cell apoptosis. Recent studies show that the ER
distribution of GSH and GSSG was close to 5-to-1 [40], more reduced
than previously reported [39]. The implication of a more reducing
redox environment for proper protein folding remains to be
investigated.
It is increasingly evident that the speciﬁcity of GSH in redox
signaling can be attributed in part to the existence of such dis-
tinct intracellular redox compartments and the associated redox
reactions therein. What remain unresolved are the mechanistic
details of how changes in compartmental GSH redox status regu-
late signal transduction pathways that impact a cell's survival or
death.3. Disruption of GSH redox status and oxidant-induced apoptosis
The role of GSH in maintaining cell integrity against exogenous or
endogenous derived ROS is well known. Moreover, the current para-
digm suggests that a decrease of cellular GSH below a threshold level
constitutes an apoptotic signal that initiates death receptor activation
or mitochondrial apoptotic signaling. In contrast, increased cellular
GSH levels confer protection against Fas-induced apoptosis, a process
that was attributed to the antioxidant activity of GSH [41]. Similarly,
modulation of the cellular GSH synthetic capacity through increased
cysteine uptake decreased the vulnerability of dopaminergic neurons
to oxidative stress [42], and up-regulating GCL expression protected
mouse liver hepatoma cells against As3+-induced apoptosis, a process
that was associated with preserving mitochondrial function and block-
ing caspase activation [43]. These collective ﬁndings support a central
role of GSH in the protection of cells against different apoptotic stimuli;
indeed impairment of cellular GSH redox homeostasis caused by GSH
oxidation or by GSH efﬂux has been documented to contribute to
apoptosis.
Studies in our laboratory have consistently shown that an early dis-
ruption of the GSH status in the form of a spike in GSSG formation, typ-
ically within minutes of oxidant exposure, preceded oxidant-induced
activation of mitochondrial apoptotic signaling in different cell types
[44–47]. Additionally, we found that the recovery of cellular GSH/
GSSG redox status post-oxidant exposure did not rescue cells from the
apoptotic outcome, indicating that apoptotic signaling has advanced
within this early, narrowwindow of GSH/GSSG redox shift. Importantly,
the ﬁnding that NAC, a thiol antioxidant, when administered prior to ox-
idant challenge blocked oxidative (e.g., tert-butylhydroperoxide, tBH) or
carbonyl (e.g., methylglyoxal) stress induced cell apoptosis is consistent
with the notion that an apoptotic death signal was triggered by an early
loss of GSH-to-GSSG balance [44,45,47,48]; signiﬁcantly, post-oxidant
treatment with NAC did not affect the apoptotic outcome. Furthermore,
an apoptotic susceptibility to tBH decreased following transition of
PC12 neuronal cells from the naïve to differentiated phenotype, a pheno-
typic change that was associated with increased NADPH-dependent
hydroperoxide catabolism, decreased Apaf-1 expression, and higher cel-
lular GSH redox contents [47]. This increase in cellular GSH in differenti-
ated PC12 cells during peroxide challenge is somewhat unexpected
given that under physiological conditions, cell transition from prolifera-
tion to differentiation, such as in intestinal cells, is oft associated with a
more oxidized GSH redox potential [49–51]. Whether such differential
cellular GSH responses are cell type speciﬁc or related to differences in
the control of GSH status under normal or oxidizing conditions are inter-
esting questions that warrant further study.3.1. Cellular GSH and MAPK-induced apoptosis
The activation of mitogen-activated protein kinase (MAPK) by dif-
ferent stimuli that induce oxidative stress is known to trigger cellular
apoptosis [52]. Intracellularly, there are three classes of MAPKs, namely,
extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase
(JNK), and p38 [52]. Transduction of signaling cascade is complex and
involves sequential phosphorylation events in which activation of a
speciﬁc MAPKKK (MAP3K, MAPK kinase kinase) leads to downstream
activation of a speciﬁc MAPK kinase (MAP2K), that in turn activates
the MAPKs [53]. Notably, activation of JNK and p38 MAPK has been
linked to stress-induced apoptosis, a process that occurred through ei-
ther the ASK-1 (apoptosis signal-regulating kinase-1, a MAP3K),
MEK4/7 (MAPK kinase-4/7) and JNK, or the ASK-1, MEK 3/6 (MAPK
kinase-3/6) and p38 axis [52,54]. Speciﬁcally, Trx-1/ASK-1 and GST-pi/
JNK interactions are sensitive to ROS [54–56], but only reduced Trx-1
and GST-pi binds to and blocks downstream apoptotic signaling.
Viewed simply, the Trx-1/ASK-1 and GST-pi/JNK complexes function
as redox switches that can be turned on or off by ROS [56,57].
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apoptotic pathways is incompletely understood. Since GSH is a key de-
terminant of intracellular redox homeostasis and amajor antioxidant, it
is conceivable that cellular GSH is a modulator of MAPK pathways. In-
deed, in several cell models, GSH/GSSG redox imbalance was shown
to activate MAPK signaling and exacerbate apoptosis. For example,
aloe-emodin (AE)-induced ROSmediated cellular GSH/GSSG imbalance
and redox activation of glutathione S-transferase pi (GST-pi)/JNK sig-
naling in hepatoma cells [58]. Importantly, sustained JNK activation
promoted mitochondrial apoptotic signaling [58]. Similarly, exposure
of neuroblastoma SH-SY5Y cells and mouse primary cortical neurons
to tetrahydrobiopterin (BH4) increased ROS production and decreased
cellular GSH that resulted in p38-mediated DNA damage and apoptosis
[59]. Signiﬁcantly, BH4-mediated inhibition of glucose uptake de-
creased GSH regeneration from GSSG and potentiated p38 MAPK in-
duced apoptosis [59].
In other studies, the disruption of de novo GSH synthesis with BSO
(L-buthionine (S,R)-sulfoximine)was shown tomediate redox activation
of MAPK and apoptotic signaling. For instance, exposure of BSO-treated
breast cancer cells to Aplidin® led to the activation of JNK and p38 path-
ways and cell apoptosis [60]. Likewise, apoptosis of BSO-treated HepG2
cells induced by andographolide occurred via activation of the ASK-1/
MEK4/JNK axis [61]. Notably, exogenous addition of thiols (NAC, GSH)
prevented toxicant-induced MAPK activation, consistent with a role for
GSH in MAPK function and cellular stress responses [60]. Interestingly,
exposure of human promonocytic U937 cells to BSO activated survival
mechanisms, viz., the proteasome, heat shock protein, and NF-κB sys-
tems which collectively blunted the propagation of mitochondrial
apoptotic signaling despite mitochondria-to-cytosol release of cyt c and
AIF [62]. The reason for cell type speciﬁc differential activation of apopto-
tic or survival signals at lowGSH is not clear, andmay be related to a cel-
lular “GSH threshold”. What is clear, however, is that a cell's phenotypic
outcome is sensitive to cellular GSH, and that decreased GSH levels
through inhibition of its synthesis could result in cell apoptosis or cell
survival. A role for GSSG in the initiation of mitochondrial apoptotic sig-
naling is intriguing. Extracellular GSSGwas shown to selectively activate
the ASK-1/MEK3/6/p38 axis in U937 cells through a mechanism that in-
volved GSSG-induced thiol/disulﬁde exchange at the plasma membrane
and formation of proteinmixed disulﬁdes [63]. This redox stress, in turn,
activated the Trx-1/ASK-1 complex and the p38 pathway [63]. The ﬁnd-
ing that each of these eventswas prevented by treatmentwithGSH ethyl
ester is consistent with a central role for GSH [63]. Curiously, neuroblas-
toma SH-SY5Y cells were resistant to GSSG-induced apoptosis [64].
However, cell apoptosis was enhanced by BSO pretreatment associated
with increased ROS production and JNK activation [64], suggesting that
a GSH threshold is requisite for the GSSG effect in MAPK signaling and
apoptosis in these cells.
GSH modulation of cellular Trx-1 redox status and downstream
ASK-1 signaling was demonstrated in adenocarcinoma gastric cells
(ACS) [65]. Exposure of ACS cells to the GSH oxidizing agents, diamide
or dithionitrobenzoate, promoted Bax upregulation and the mitochon-
drial apoptotic cascade [65]. Speciﬁcally, redox activation of Trx1/
ASK-1/p38 signaling was triggered by diamide-induced increases in
GSSG and decreases in S-glutathiolated proteins [65]. The resistance of
ACS cells to H2O2 and other ROS producing systems (paraquat,
xantine/xantine oxidase) was correlated with Nrf2-dependent in-
creases in cellular GSH and S-glutathiolated proteins [65]. Interestingly,
the opposite responses were elicited in neuroblastoma SH-SY5Y cells,
i.e., sensitivity to H2O2 and resistance to diamide [66]. In this instance,
H2O2 activated Trx1/p38/p53 signaling and cell apoptosis while di-
amide activated ERK signaling and Nrf2-dependent increases in cellular
GSH and pro-survival heme oxygenase-1 expression [66].
As it is with numerous metabolic functions, GSH-dependent
post-translational modiﬁcation of protein redox active cysteines
(see Section 5.1) is implicated in MAPK signaling, though less
well understood. Studies by Cross et al. demonstrated thatsite-speciﬁc S-glutathiolation of cysteine1238 in the ATP binding
domain resulted in menadione (MQ)-mediated inhibition of
MEKK1 activity [67]; however, the precise association of oxidative
stress and S-glutathiolation in the activation/inactivation of specif-
ic MAPK pathways and cell apoptosis remains to be established.
While redox regulation of MAPK signaling is clearly a complex pro-
cess, it is evident that GSH plays a central role. The differential ac-
tivation of either death or survival signaling complexes is likely a
function of the cellular GSH content [65,66], and signiﬁcantly, the
biological outcome (apoptosis or survival) is likely to be cell type
dependent.
3.2. Role of mitochondrial GSH in oxidant-induced intrinsic apoptotic
signaling
In recent years, the mitochondria have received considerable inter-
est as a central organelle in apoptotic signaling and cellular death.
Indeed, signals triggered by death-receptor activation or initiated at
the mitochondria converge to induce the release of mitochondrial
apoptogenic proteins into the cytosol and initiate themitochondrial ap-
optotic cascade (Fig. 1). The GSH/GSSG couple is considered the major
redox system inmaintainingmatrix redox homeostasis, and in preserv-
ing the redox state of mitochondrial proteins and the integrity of mito-
chondrial DNA against mitochondria-derived ROS. Not surprisingly,
selective depletion of the mtGSH pool was associated with decreased
activity of mitochondrial respiratory complexes, increased ROS produc-
tion, loss of mitochondrial membrane potential, and mitochondrial re-
lease of apoptogenic factors in different cell models. For example, in
diabetic cardiomyocytes oxidative stress-mediated oxidation of mito-
chondrial, but not cytosolic, GSH induced ΔΨ loss and caspases-9 and
-3 activation, consistent with the contribution of selective mtGSH de-
pletion to apoptotic induction [68]. Similarly, in human B lymphoma,
mtGSH decreases initiated cell apoptosis in an ROS-dependent manner
involving the collapse ofΔΨ, release of cyt c, and activation of caspase-3
[69].
A direct link between loss of mtGSH and increased apoptosis was
demonstrated in a variety of cell types exposed to various apoptotic stim-
uli including hypoxia [70], oxidants, such as tBH [71], or xenobiotics such
as aromatic hydrocarbons [72], ethanol [73], and β-phenethyl isothiocya-
nate (PEITC) [74]. Ethanol toxicitywas associatedwith changes in themi-
tochondrial membrane ﬂuidity and decreased mtGSH transport, events
that sensitized hepatocytes to acetaminophen- and TNF-α-induced
apoptosis [73,75]. Notably, mtGSH depletion was pre-requisite in
TNFα-mediated hepatocytic apoptosis that was preceded by tBid/
Bax-initiated mitochondrial membrane permeabilization, cyt c release,
apoptosome assembly and caspase-3 activation [76]. In colonic cells, the
oxidation of mtGSH was central to MQ-induced mitochondrial dysfunc-
tion and cyt c-dependent activation of intrinsic apoptotic signaling [50].
Precisely how a loss in mtGSH induced a failed mitochondrial function
is unclear. In kidney and liver, cisplatin-induced cell apoptosis was linked
to mtGSH/GSSG imbalance, decreased NADPH, and cisplatin-mediated
oxidative damage to cardiolipin andaconitase, resulting in impairedmito-
chondrial energetic metabolism and caspase-3 activation [77,78]. More
recent studies revealed that rapid depletion of mtGSH triggered
PEITC-induced ROS/RNS production and apoptosis in HL-60 and Raji
cells through destabilization of the Fe–S cluster of the NDUGS3 subunit
and induction of complex I degradation, resulting in inhibition of respira-
tion and collapse ofΔΨ [74]. It is noteworthy that amoderate decrease in
hepatocyte mtGSH induced by moderate hypoxia did not elicit cell apo-
ptosis, suggesting that a critical threshold ofmtGSH lossmust be achieved
for apoptotic initiation [70].
Additionally, mtGSH depletion can control the activity of the mi-
tochondrial permeability transition (MPT). Early evidence implicate
the decrease of mtGSH with MPT opening, a process that occurred
through redox modulation of the ANT protein that led to
mitochondria-to-cytosol release of apoptogenic factors like cyt c
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status is, in fact, a key modulator of MPT opening in cardiomyocytes
[81]. A sequential decrease in mtGSH/GSSG from 300:1 to 20:1 was
found to elicit sequential opening of the mitochondrial inner mem-
brane anion channel (IMAC) and PTP. At GSH/GSSG ratios ranging
from 150:1 to 100:1 oscillations in ΔΨ were noted while ratios
more oxidized than 50:1 caused irreversible mitochondrial depolar-
ization and permanent channel opening associated with mitochon-
drial collapse [81]. It is notable that cardiomyocytes exhibit a
highly reduced basal mtGSH redox state which would be consistent
with an enhanced sensitivity of cardiac cells to oxidative stress. In-
triguingly, despite mtGSSG increases, a “preconditioning-like” effect
of low levels of carbon monoxide (CO) was shown to mitigate oxida-
tive stress induced apoptosis in primary cultures of astrocytes [82].
Reportedly, CO mediated the S-glutathiolation of ANT, an event
that inhibited channel function, ΔΨ collapse, mitochondria swelling,
and cyt c release [82]. However, whether CO conditioning is a univer-
sal and biologically relevant process in apoptotic prevention in
mammalian cells remains to be explored.
A better understanding of the role of altered mtGSH/GSSG redox
status in apoptotic initiation comes from detailed studies on the
modulation of cytosol-to-mitochondria GSH transport carriers
using chemical and genetic means. Lash and colleagues have dem-
onstrated that over-expression of the DIC and OGC carriers in rat
renal proximal tubular NRK-52E cells afforded protection against
tBH- and S-(1,2-dichlorovinyl)-L-cysteine-induced apoptosis in as-
sociation with increased mtGSH levels [83,84]. This protection was
nulliﬁed in NRK-52E cells over-expressing a double-cysteine mu-
tant of OGC, a non-functional mtGSH carrier [84]. Using similar
strategies, we found that mtGSH preservation in colonic cells was
important for maintaining mitochondrial respiratory activity and
ΔΨ upon MQ exposure [50]. Speciﬁcally, increased mtGSH trans-
port mitigated MQ-induced mtGSSG increase and prevented ATP
decreases, ΔΨ collapse, mitochondria-to-cytosol cyt c transloca-
tion, and caspases-9 and -3 activation [50]. We further found that
despite the inhibition of OGC or DIC functions where mtGSH trans-
port was signiﬁcantly compromised, respiratory substrate supply
for mitochondrial oxygen consumption was minimally affected.
This would be consistent with a high afﬁnity (low Km) of the carriers
for the metabolic substrates, such as α-ketoglutarate, malate, or
succinate. Thus, mitochondrial failure associated with decreased
OGC/DIC activities was unlikely to be related to decreased supply
of mitochondrial substrates, but rather to decreased mtGSH. Other
studies in CHO cells similarly demonstrated that over-expressing
Bcl-2 and OGC proteins in the outer and inner mitochondria mem-
brane, respectively, increased cell resistance to oxidative challenge
in conjunction with enhanced mtGSH transport and elevated
mtGSH levels [33]. In contrast, H2O2-induced CHO apoptosis was
exacerbated by inhibition of OGC activity or treatment with the
BH3 mimetic, HA14-1, a speciﬁc Bcl-2 inhibitor that displaces GSH
from the BH3 groove which resulted in disrupted Bcl-2/OGC inter-
action and depleted mtGSH [33].
3.3. Mitochondrial GSH and oxidant-induced mitochondrial DNA damage
Mitochondrial DNA (mtDNA) is a circular double-stranded DNA
organized in nucleoids and encodes 13 polypeptides of the respirato-
ry chain and tRNAs that are necessary for protein synthesis within the
mitochondria [85]. The mitochondrial genome lacks histones and is
situated in close proximity to the mitochondrial electron transport
chain, a constant source of ROS; in consequence mtDNA is highly sus-
ceptible to oxidative damage [86]. The mechanism by which oxidative
mtDNA damage initiates apoptotic signaling is unclear; a current hy-
pothesis proposes that oxidative damage to mtDNA induces a vicious
cycle of ROS-mtDNA damage through diminished transcription of mi-
tochondrial proteins and impaired electron transport which furtherexacerbates ROS production that ultimately results in mitochondrial
failure and apoptotic initiation [87,88]. How prevalent and general
this mechanism of apoptosis is among mammalian cells remains to
be determined.
The preservation of mtGSH is essential for mtDNA protection. A
direct relationship has been reported between decreased mtGSH
and increased mtDNA damage in mouse embryonic ﬁbroblasts
[89] and in brain and kidney of aging mice and rats [90]. In rat
liver mitochondria, hemin-induced mtGSH loss exacerbated
tBH-mediated oxidative mtDNA damage and mtDNA region dele-
tion, that led to the translocation of pro-apoptotic Bax and Bcl-xL
to the mitochondria and activation of the intrinsic apoptotic cas-
cade [91]. Our study in colonic epithelial cells demonstrated that
MQ-induced mtGSH redox imbalance paralleled dose-dependent
increases in oxidative damage to mtDNA, consistent with a corre-
spondence of the two events [92]. Moreover, the collective ﬁndings
that NAC or overexpression of OGC, and BSO or inhibition of mtGSH
transport, respectively blunted or exaggerated mtGSH imbalance
and mtDNA damage [92] support our interpretation that the sus-
ceptibility of mtDNA to oxidative stress is sensitive to the mtGSH
redox status. What remains to be determined is the mechanistic re-
lationship between mtGSH and mtDNA, i.e., whether mtGSH pre-
vents mtDNA damage through quenching of ROS, or whether
mtGSH promotes mtDNA repair through activating mtDNA repair
enzymes. Interestingly, our recent studies revealed that the activity
of the mitochondrial AP endonuclease was in fact increased by MQ
stress and associated mtGSH depletion (Circu, Harrison and Aw,
unpublished). While the signiﬁcance of this ﬁnding is yet unclear,
it is consistent with redox-dependent stimulation of DNA repair
post oxidative stress.
4. GSH efﬂux and apoptotic signaling
Prevailing evidence indicates that the export of cellular GSH into the
extracellular space constitutes an important event that either initiates
apoptotic signaling or promotes apoptotic progression. In U937 or
HepG2 cells, the extrusion of cellular GSH was shown to be an early
event in puromycin- or etoposide-induced apoptosis [93]. The fact
that the blockage of GSH export completely rescued these cells fromap-
optosis is consistent with the notion that GSH efﬂux is a trigger for ap-
optotic signaling at the cell membrane [93]. Indeed, UVA-mediated
cellular GSH extrusion in HaCaT cells preceded phosphatydyl serine
(PS) externalization at the plasmamembrane, an event that was associ-
ated with the later stages of the apoptotic process [94]. Different apo-
ptotic stimuli such as death-receptor activation [95], drug- [96] or
chemical toxins [97,98]were shown to promote the activation of specif-
ic GSH carriers at the plasmamembrane and induce cellular GSH efﬂux.
Among the speciﬁc plasmamembrane transporters that are involved
in GSH extrusion, the multidrug resistance protein (MRP) contributes
majorly to apoptotic progression in many cell models. For example, in
HEK293 cells, FasL binding or staurosporine (STP) exposure stimulated
MRP-mediated GSH release and triggered cell apoptosis, characterized
by caspase-3 activation, increased DNA fragmentation, and PS externali-
zation [99,100]. Additionally, FasL-inducedGSH efﬂux paralleled apopto-
tic volume decrease and disrupted intracellular ionic homeostasis via K+
loss. These two events were important players in regulating the progres-
sion of death receptor-mediated apoptosis in lymphoid cells [101].
Somewhat surprisingly, HEK293 cells overexpressing the MRP1 carrier
were more resistant to Fas- or STP-induced apoptosis than normal
HEK293 cells [99]; the resistance to apoptosis was attributed to a higher
basal GSH level in MRP1 overexpressing cells. Thus, it appears that the
loss of GSH through efﬂux should accompany a threshold of intracellular
GSH depletion in order for apoptosis to be initiated [99]. The organic
anion transporting polypeptide (OATP) is another plasma membrane
transporter that is involved in the active export of cellular GSH upon
FasL exposure. OATP-mediated GSH efﬂux induced Jurkat cell apoptosis
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worthy that elevated extracellular GSH concentration blockedGSH efﬂux
suggesting that the GSH concentration gradient across the plasmamem-
brane is a major driving force for GSH export [102]. Since plasma GSH
concentrations are typically several orders of magnitude lower than cel-
lular GSH levels (μM versus mM), vascular cells would be highly vulner-
able to agents that induce GSH efﬂux, such as STP. In colonic epithelial
cells, STP-induced cell apoptosis was also triggered by GSH efﬂux driven
by extracellular GGT-catalyzed GSH hydrolysis [103]. Notably, cell
apoptosis was prevented by the inhibition of GGT suggesting that the ac-
tivity of GGT at the intestinal apical membrane can maintain a high
intra-to-lumen GSH concentration gradient that favors apoptosis. In
these cells, STP-induced apoptosis occurredwithout changes in the cellu-
lar GSH/GSSG redox status, and was mediated by caspase-3 activation
that was, interestingly, independent of caspase-8 or -9 functions [103].
Though uncommon, the export of GSSG has, in some cell types such as
endothelial cells, been shown to contribute to cell death. Prolonged
MRP1-dependent extrusion of GSSG during oxidative stress led to intra-
cellular redox imbalance and caspase-3 activation [104].
The mechanism linking GSH efﬂux to the initiation of apoptotic
signaling at the cell membrane is unclear. GSH efﬂux has been widely
reported to precede ROS production, and many studies have linked
ROS-induced oxidative damage to activation of apoptotic signaling.
A study by L'Hoste et al. showed that CFTR-mediated GSH export in
renal cells following STP exposure preceded an increase in intracellu-
lar ROS production that stimulated both K+ and Cl− efﬂux that led to
the apoptotic volume decrease and apoptosis [105]. Similarly,
Cd2+-induced activation of CFTR exacerbated the efﬂux of GSH and
Cd-GSH conjugates and mediated proximal tubule cell apoptosis in
an ROS-dependent way through perturbing intracellular ionic ho-
meostasis and decreasing cell volume [98]. Yet, other studies contend
that the cellular GSH content is the determinant of apoptosis rather
than ROS production or oxidative damage. Our ﬁndings in colonic ep-
ithelial cells showed that STP-induced apoptosis occurred without
changes in the cellular GSH/GSSG redox status, indicating a lack of ox-
idative stress [104]. Similarly, arsenic trioxide (ATO)-induced Calu-6
cell apoptosis occurred via depletion of intracellular GSH rather
than increase in ROS production [97]. Signiﬁcantly, ATO-induced apo-
ptosis was blunted by NAC and exacerbated by BSO (agents that mod-
ulate cellular GSH), but not affected by ROS scavengers (e.g. tempol,
tiron, trimetazine) or by the addition of superoxide dismutase or cat-
alase [97].
In fact, Franco et al. [106] suggested that ROS production secondary
to FasL-mediatedGSH depletion in lymphoid cellswas a bystander phe-
nomenon that had limited contribution to apoptotic progression. The
efﬂux of GSH induced by a synthetic triterpenoid, CDDO-Me, triggered
cell apoptosis via JNK activation and DR5 upregulation that mediated
caspase-8 activation, independently of ROS production [106]. In
human leukemicmonocyte lymphoma cells, GSH efﬂux induced by res-
veratrol preceded Bax translocation to mitochondria that was followed
by ROS production, loss of mitochondrialΔΨ and caspase-3-dependent
apoptosis [96]. However, the blunting of ROS production failed to pre-
vent GSH extrusion and cell apoptosis whereas exogenous pre-
treatment with high levels of thiol (GSH, NAC) or inhibition of GSH
efﬂux effectively prevented cell death [96]. This means that the induc-
tion of GSH efﬂux and cell apoptosis by resveratrol are biologically asso-
ciated events that are distinct from its induction of ROS generation, thus
supporting a “bystander” effect for ROS under these conditions. Collec-
tively, these studies underscore the importance of extracellular GSH ex-
port as an important trigger of apoptotic signaling originating at the cell
membrane. The extent that this mechanism is cell type-speciﬁc and
context-dependent remains to be determined. Further studies are also
necessary to delineate what role, if any, secondary production of ROS
plays in GSH efﬂux-mediated apoptotic initiation.
Clearly, our current understanding of the role of GSH efﬂux in me-
diating cell apoptosis is incomplete; data to date highlight thediversity of GSH efﬂux-dependent apoptosis among different cell
types. Signiﬁcantly, differences in GSH redox status (GSH or GSSG),
apoptotic stimuli, expression of speciﬁc plasma membrane trans-
porters, and importance of intrinsic or extrinsic apoptotic pathways,
are all contributing factors to the uniqueness of the death process in
individual cell types.
5. S-glutathiolation and apoptosis
5.1. Mechanism of protein S-glutathiolation
Many proteins contain redox-sensitive thiols that can bemodiﬁed by
GSH during basal or mild oxidative stress conditions that yield mixed
disulﬁdes, a post-translational modiﬁcation called S-glutathiolation.
Given that GSH modiﬁcation of cysteine residues is reversible, protein
S-glutathiolation has been investigated as amechanismof control of pro-
tein function, particularly cellular signaling pathways in a manner simi-
lar to phosphorylation [107]. The disulﬁde bonds formed between GSH
and cysteine moieties of proteins can be reversed by cellular thiol trans-
ferases such as Trx or glutaredoxin (Grx), but to date, the exact mecha-
nism involved in the process of S-glutathiolation/de-glutathiolation has
not been completely elucidated. Recent evidence suggests that the
formation of S-glutathiolated proteins may occur spontaneously or is
catalyzed by speciﬁc enzymes [108,109] as depicted in Fig. 3. Early data
support the notion that a change in the cellular GSH-to-GSSG ratio is re-
sponsible for S-glutathiolated protein formation through thiol/disulﬁde
exchange reactions between a protein containing a reduced sulfhydryl
group (Pr-SH) and GSSG or between Pr-SH and another S-glutathiolated
protein (Pr-SSG). However, since elevated GSSG levels are associated
with oxidizing conditions, the formation of S-glutathiolated proteins by
this thiol/disulﬁde exchange mechanism would more likely occur under
pathological situations. Another mechanism of protein S-glutathiolation
within cells is the reaction between the SH group of a protein (or GSH)
with “activated” protein cysteine moieties (or GSH), such as the
S-nitrosyl (\SNO), sulfenic acid (\SOH), or thiyl radical (\S•) deriva-
tives (Fig. 3). Studies with puriﬁed proteins in vitro or with cell extracts
have demonstrated such a link between the formation of these oxidized
derivatives of Pr-SH or GSH during oxidative and nitrosative stress with
the promotion of protein S-glutathiolation [110,111]. How biologically
relevant this mechanism is in the post-translational control of normal
cell metabolism and function remains to be investigated.
5.2. S-glutathiolation of apoptotic machinery
Increasingly, the speciﬁc activation/deactivation of a protein via
S-glutathiolation is viewed as an important regulator of cellular
events and signaling pathways, including those involved in the apo-
ptotic cascade [112]. Ample evidence supports the pathophysiological
relevance of S-glutathiolation in receptor-mediated apoptotic signal-
ing. Notably, TNF-α- or FasL-induced apoptosis were highly suscepti-
ble to modulation by S-glutathiolation. For example, S-glutathiolation
of the Fas receptor at Cys294 was readily promoted through Grx1 deg-
radation mediated by Fas-induced activation of caspases-8 and/or -3
[113]. In lung epithelial cells, this redox-dependent modiﬁcation
and facilitation of Fas/FasL binding enhanced receptor aggregation
into lipid rafts and formation of the DISC complex, followed by the
ampliﬁcation of downstream propagation of the extrinsic apoptotic
cascade [113]. Another evidence in mouse alveolar epithelial cells
showed that the magnitude of NF-κB activation upon FasL binding
or H2O2 exposure was also controlled by S-glutathiolation [114]. Sig-
niﬁcantly, inactivation of IKK kinase activity by S-glutathiolation of
Cys179 of the β-subunit of the IKK complex prevented the activation
of NF-κB survival signals and promoted cell apoptosis [114]. A similar
link between Grx1 function and NF-κB activity in apoptotic suscepti-
bility of cardiomyocyte has been documented. Speciﬁcally, dimin-
ished Grx1 activity in rat embryonic cardiomyocytes (H9c2 cells) or
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NF-κB-target anti-apoptotic genes such as Bcl-2 and Bcl-xL which
rendered cells highly susceptible to oxidants [115]. Increased
S-glutathiolation and deactivation of one or more components of
the signaling pathway were suggested as a mechanism for attenuated
NF-κB activity [115]. An interesting study by Pan and Berk implicates
Grx as a major factor in controlling the deglutathiolation status of
caspase-3 in TNF-α-induced apoptosis in endothelial cells [116].
TNF-α-induced increase in Grx activity facilitated caspase-3
de-glutathiolation and its activation was effectively inhibited by
small interfering RNA against Grx [116]. In HL-60 cells, caspase‐3 ac-
tivation induced by actinomycin D treatment was controlled through
GSH/GSSG-dependent S-glutathiolation of Cys135 and Cys45 of the
p17 and p12 subunits of caspase-3, respectively [117]. Interestingly,
S-glutathiolation of pro-caspases-3 and -9 and caspase-3 can occur
at physiologic GSSG concentrations, suggesting that basal thiol–disul-
ﬁde exchanges between GSSG and protein-SH is a normal, dynamic
biological process [117]. While the evidence exists, the jury is still
out as to whether S-glutathiolation can be deemed a master regulator
of cell apoptosis through its interaction with the executioner
caspase-3. The degree to which apoptotic components upstream of
caspase-3, if any, are amenable to S-glutathiolation and which partic-
ular cysteine residues are susceptible or targeted remains to be
explored.
S-glutathiolation of mitochondrial components in the intrinsic
apoptotic cascade is less well understood. Existing evidence
suggests that GSH-dependent thiolation of mitochondrial proteins
such as subunits of complex I of the mitochondrial respiratory
chain may lead to mitochondrial dysfunction and the initiation of
intrinsic apoptotic signaling. Intramitochondrial formation of
S-glutathiolated products during oxidative stress is expected given
that the mitochondria lack an export mechanism for GSSG. We
and others have demonstrated that oxidant-induced decrease in
mtGSH was accompanied by increased formation of mitochondrial
S-glutathiolated proteins [50,118,119]. Notably, mitochondria-derived
superoxide production was increased by reversible S-glutathiolation
of redox-sensitive cysteines of the 51- and 75-kDa subunits of complexFig. 3. Proposedmechanisms of protein S-glutathiolation. There are fourmechanisms bywhich
exchange between protein-SH (Pr-SH) and GSSG. Since the thiol–disulﬁde reaction requires a
mostly associated with pathological conditions. Mechanisms B–D illustrate the interactions of
atives. Two electron oxidation of Pr-SH generates Pr-SOH that reacts with GSH to form Pr-SSG
with GSH or Pr-SH respectively (mechanism C). Pr-SSG can also be formed through reaction
GSH gives rise to the respective thiyl radicals which react with GSH or Pr-SH, respectively, y
Pr-SH produces Pr-SSG. S-glutathiolated proteins can be formed through a two‐step reaction
electron oxidation of protein or GSH gives rise to the respective thiyl radical; this radical furthe
(mechanism D). Intracellularly, glutaredoxin can catalyze the reaction of GS•with proteins to g
icals of protein and GSH also forms the S-glutathiolated protein (mechanism D). Additionally,
reaction between Pr-S• and GS• also produced Pr-SSG (mechanism D).I that led tomtGSH oxidation, mitochondrial dysfunction and cell death
[120]. Similarly, oxidative conditions can induce S-glutathiolation of
Cys531 and Cys704 of the 75kDa subunit of complex I of bovine heartmi-
tochondria [121] and S-nitrosation of the 75kDa subunit of complex I of
rat heart mitochondria [122]. Such ROS/RNS-induced oxidative
impairment of complex I would compromise respiratory activity that
leads to mitochondrial dysfunction and apoptotic initiation. In the
brain of a mouse model of Parkinson's disease, GSH depletion was
linked to enhanced susceptibility of six complex I cysteine residues to
S-glutathiolation and S-nitrosation [123]. Three of the cysteines were
within the subunits containing iron–sulfur clusters that are essential
for electron transport, consistent with a role for GSH in modulating mi-
tochondrial electron ﬂux and respiratory activity.
It is noteworthy that constitutive S-glutathiolation of the cysteine
thiols of complex I [124] and complex II [125] subunits under physiolog-
ical conditions is believed to be a protectivemechanism against oxidation
by mitochondria-derived ROS. Indeed, cysteine de-glutathiolation of mi-
tochondrial complex I and II proteins rendered these cysteines susceptible
to oxidative stress and irreversible oxidativemodiﬁcation. For example, in
post-ischemic rat heart, de-glutathiolation of the 70-kDa FAD-binding
subunit of complex II attenuated the efﬁciency of electron transfer,
resulting in increased electron leak and superoxide formation at this site
[125]. Conversely, reversal of de-glutathiolation diminished ROS produc-
tion throughnormalization of electron transport function [125]. In human
dopaminergic neuroblastoma SH-SY5Y cells, neuromelanin-induced in-
trinsic apoptosis similarly occurred through increased de-glutathiolation
ofmitochondrial complex I, causing the dissociation of themacromolecu-
lar structure of complex I and triggering ΔΨ collapse, cyt c release, and
caspase-3 activation [124]. Moreover, neuromelanin-mediated apoptosis
is ROS-dependent [126].
While it is conceivable that all protein cysteine residues can be
glutathiolated, it is abundantly clear that it is the modiﬁcation of
speciﬁc cysteine residues that contributed to altered protein function.
Precisely which speciﬁc cysteine moieties are vulnerable to or how
they are selectively targeted for glutathiolation and oxidative modiﬁ-
cations are unknown. The identiﬁcation of such redox active cysteines
in individual proteins or protein sets should provide fruitful avenuesS-glutathiolated proteins (Pr-SSG) can be formed. MechanismA illustrates thiol–disulﬁde
signiﬁcant increase in GSSG levels, the formation of Pr-SSG via this mechanism would be
Pr-SH or GSH with S-nitrosyl (\SNO), sulfenic acid (\SOH), or thiyl radical (\S•) deriv-
. During nitrosative stress, Pr-SSG is formed from increased reactions of Pr-SNO or GSNO
s with thiyl radicals of Pr-SH (Pr-S•) and GSH (GS•). One electron oxidation of Pr-SH or
ielding Pr-SSG (mechanism D). Additionally, glutaredoxin-catalyzed reaction of GS• with
of the activated thiyl radical forms of the protein thiol (Pr-S•) and GSH (GS•). Firstly, one
r reacts with the GSH and protein thiol, respectively, to form the S-glutathiolated protein
enerate S-glutathiolated proteins. In parallel, a single-step reaction between the thiyl rad-
glutaredoxin-catalyzed reaction of GS• with Pr-SH produces Pr-SSG. Finally, a single-step
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be forthcoming, the current evidence provides important insights
into the redox regulation of mitochondrial activity, uniquely through
S-glutathiolation of key mitochondrial respiratory proteins.
6. Perspective
Apoptosis research has come a long way from the early recogni-
tion of apoptosis as a highly orchestrated programmed cell death
that is vital in organ homeostasis. Decades of research have also ad-
vanced our mechanistic understanding of the receptor-mediated ex-
trinsic and mitochondria-mediated intrinsic pathways of apoptosis.
Current and future research into the regulation of apoptotic signaling
is expected to yield new and exciting insights, particularly in the area
of redox signaling. In this regard, post-translational modiﬁcation of
redox sensitive cysteines through glutathiolation is emerging to be
an intense and fruitful area of future endeavor. Signiﬁcantly, the con-
ceptual integration of how S-glutathiolation functions as a regulatory
mechanism in controlling mitochondrial protection and mitochondri-
al apoptotic signaling, i.e., a “yin-yang” role in mitochondrial regula-
tion in cell survival and death will be a challenge for future studies.
Also, how the cellular GSH/GSSG redox status, its intricate interaction
with other redox systems and its unique subcellular compartmenta-
tion all come together in the elegant control of apoptotic signaling
will continue to fascinate and challenge new research directions.
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